Description of the GiACTA trial (Stone et al, N. Engl. J. Med. 2017), a Phase III clinical trial of tocilizumab (Actemra) for the treatment of giant cell arteritis (GCA).
Tag: giant cell arteritis
Description of the GiACTA trial (Stone et al, N. Engl. J. Med. 2017), a Phase III clinical trial of tocilizumab (Actemra) for the treatment of giant cell arteritis (GCA).